Duration and Thresholds of the Ischemic Penumbra in Different Species

The Ischemic Penumbra

Volumn , Issue , 2007, Pages 37-57

  Touzani, Omar ^a   Baron, Jean Claude ^b  

^a UNIVERSITÉ DE CAEN   (France)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349899567     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781420047356-8     Document Type: Chapter

References (171)

1. Macrae IM. New models of focal cerebral ischaemia. Br J Clin Pharmacol 1992; 34(4):302-308.
2. Hossmann KA. Animal models of cerebral ischemia. Review of literature. Cerebrovasc Dis 1991; 1:2-15.
3. Hata R, Mies G, Wiessner C, et al. A reproducible model of middle cerebral artery occlusion in mice:hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 1998; 18(4):367-375.
4. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22:391-397.
5. Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 1999; 399(6738 suppl):A7-A14.
6. Nagasawa H, Kogure K. Correlation between cerebral blood flow and histologic changes in a new model of middle cerebral artery occlusion. Stroke 1989; 20:1037-1043.
7. Zea Longa E, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20:84-91.
8. Memezawa H, Smith ML, Siesjö BK. Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 1992; 23:552-559.
9. Kaplan B, Brint S, Tanabe J, et al. Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke 1991; 22:1032-1039.
10. Buchan AM, Xue D, Slivka A. A new model of temporary focal neocortical ischemia in the rat. Stroke 1992; 23:273-279.
11. Garcia JH, Liu KF, Ho KL. Neuronal necrosis after middle cerebral artery occlusion in wistar rats progresses at different time intervals in the caudoputamen and cortex. Stroke 1995; 26:636-643.
12. Li Y, Chopp M, Garcia JH, et al. Distribution of the 72-kd heat shock protein as a function of transient focal cerebral ischemia in rats. Stroke 1992; 23:1292-1298.
13. Zhang RL, Chopp M, Garcia JH, et al. Temporal profile of ischemic tissue damage, neurotrophil response, and vaccular plugging following permanent and transient (2 h) middle cerebral artery occlusion in the rat. J Neurol Sci 1994; 125:3-10.
14. Hata R, Maeda K, Hermann D, et al. Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 2000; 20:306-315.
15. Hara T, Mies G, Hossmann KA. Effect of thrombolysis on the dynamics of infarct evolution after clot embolism of middle cerebral artery in mice. J Cereb Blood Flow Metab 2000; 20(10):1483-1491.
16. Huang J, Kim LJ, Mealey R, Marsh et al. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 1999; 285:595-599.
17. Yrjanheikki J, Tikka T, Keinanen R, et al. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999; 96:13496-13500.
18. Phillips JB, Williams AJ, Adams J, et al. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke 2000; 31:1686-1693.
19. Savitz SI, Erhardt JA, Anthony JV, et al. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab 2000; 20:1197-1204.
20. Rabuffetti M, Sciorati C, Tarozzo G, et al. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Aspchloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. J Neurosci 2000; 20:4398-4404.
21. Li H, Colbourne F, Sun P, et al. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke 2000; 31:176-182.
22. Yepes M, Sandkvist M, Wong MK, et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 2000; 96:569-576.
23. Yang Y, Li Q, Wang CX, et al. Dose-dependent neuroprotection with tiagabine in a focal cerebral ischemia model in rat. Neuroreport 2000; 11:2307-2311.
24. Williams AJ, Dave JR, Phillips JB, et al. Neuroprotective efficacy and therapeutic window of the highaffinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies. J Pharmacol Exp Ther 2000; 294:378-386.
25. Sutherland GR, Perron JT, Kozlowski P, et al. AR-R15896AR reduces cerebral infarction volumes after focal ischemia in cats. Neurosurgery 2000; 46:710-719.
26. Kawasaki-Yatsugi S, Ichiki C, Yatsugi S, et al. Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model. Neuropharmacology 2000; 39:211-217.
27. Leist M, Ghezzi P, Grasso G, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004; 305(5681):239-242.
28. Slusher BS, Vornov JJ, Thomas AG, et al. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat Med 1999; 5:1396-1402.
29. Belayev L, Liu Y, Zhao W, et al. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 2001; 32:553-560.
30. Chabrier PE, Auguet M, Spinnewyn B, et al. BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy. Proc Natl Acad Sci USA 1999; 96:10824-10829.
31. Kuroda S, Tsuchidate R, Smith ML, et al. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 1999; 19:778-787.
32. Yang Y, Li Q, Shuaib A. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia. Exp Neurol 2000; 163:39-45.
33. Carter AJ, Grauert M, Pschorn U, et al. Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL. Proc Natl Acad Sci USA 2000; 97:4944-4949.
34. Yu YM, Kim JB, Lee KW, et al. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a widetherapeutic window. Stroke 2005; 36(10):2238-2243.
35. Dijkhuizen RM, Nicolay K. Magnetic resonance imaging in experimental models of brain disorders. J Cereb Blood Flow Metab 2003; 23(12):1383-1402.
36. Gill R, Sibson NR, Hatfield RH, et al. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology. J Cereb Blood Flow Metab 1995; 15:1-11.
37. Jiang Q, Zhang RL, Zhang ZG, et al. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat. J Cereb Blood Flow Metab 1998; 18:758-767.
38. Knight RA, Ordidge RJ, Helpern JA, et al. Temporal evolution of ischemic damage in rat brain measured by proton nuclear magnetic resonance imaging. Stroke 1991; 22:802-808.
39. Dardzinski BJ, Sotak CH, Fisher M, et al. Apparent diffusion coefficient mapping of experimental focal cerebral ischemia using diffusion-weighted echo-planar imaging. Magn Reson Med 1993; 30:318-325.
40. Roussel SA, van Bruggen N, King MD, et al. Monitoring the initial expansion of focal ischaemic changes by diffusion-weighted MRI using a remote controlled method of occlusion. NMR. Bio Med 1994; 7:21-28.
41. Minematsu K, Li L, Fisher M, et al. Diffusion-weighted magnetic resonance imaging: rapid and quantitative deatection of focal bein ischemia. Neurology 1992; 42:235-240.
42. Sobesky J, Zaro Weber O, Lehnhardt FG, et al. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke. 2005; 36(5):980-985.
43. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003; 34(11):2729-2735.
44. Guadagno JV, Donnan GA, Markus R, et al. Imaging the ischaemic penumbra. Curr Opin Neurol 2004; 17(1):61-67.
45. Shen Q, Meng X, Fisher M, et al. Pixel-by-pixel spatiotemporal progression of focal ischemia derived using quantitative perfusion and diffusion imaging. J Cereb Blood Flow Metab 2003; 23:1479-1488.
46. Bardutzky J, Shen Q, Henninger N, et al. Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke 2005; 36(9):2000-2005.
47. Li F, Han SS, Tatlisumak T, et al. Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats. Ann Neurol 1999; 46:333-342.
48. Li F, Liu KF, Silva MD, et al. Transient and permanent resolution of ischemic lesions on diffusionweighted imaging after brief periods of focal ischemia in rats: correlation with histopathology. Stroke 2000; 31:946-954.
49. Zarow GJ, Graham SH, Mintorovitch J, et al. Diffusion-weighted magnetic resonance imaging during brief focal cerebral ischemia and early reperfusion: evolution of delayed infarction in rats. Neurol Res 1995; 17:449-454.
50. Neumann-Haefelin T, Kastrup A, de Crespigny A, et al. Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation. Stroke 2000; 31(8):1965-1972.
51. Guadagno JV, Warburton EA, Aigbirhio FI, et al. Does the acute DWI lesion represent penumbra as well as core? A combined quantitative PET-MR voxel-based study. J Cerebr Blood Flow Metabol 2004; 24:1249-1254.
52. Saita K, Chen M, Spratt NJ, et al. Imaging the ischemic penumbra with 18F-fluoromisonidazole in a rat model of ischemic stroke. Stroke 2004; 35(4):975-980.
53. Markus R, Reutens DC, Kazui S, et al. Topography and temporal evolution of hypoxic viable tissue identified by 18F-fluoromisonidazole positron emission tomography in humans after ischemic stroke. Stroke 2003; 34(11):2646-2652.
54. Takasawa M, Beech JS, Fryer TD, et al. Imaging of brain hypoxia in permanent and temporary middle cerebral artery occlusion in the rat using (18) F-fluoromisonidazole and positron emission tomography:a pilot study. J Cerel Blood Flow Metab 2006, Oct 11 [Epub ahead of Print].
55. Weinstein PR, Anderson GG, Telles DA. Neurological deficit and cerebral infarction after temporary middle cerebral artery occlusion in unanesthetized cats. Stroke 1986; 7:318-324.
56. Sundt TM, Grant WC, Garcia JH. Restoration of middle cerebral artery flow in experimental infarction. J Neurosurg 1969; 31:311-322.
57. Taguchi J, Graf R, Rosner G, et al. Prolonged transient ischemia results in impaired CBF recovery and secondary glutamate accumulation in cats. J Cereb Blood Flow Metab 1996; 16(2):271-279.
58. Baskaya MK, Rao AM, Donaldson D, et al. Protective effects of ifenprodil on ischemic injury size, blood-brain barrier breakdown, and edema formation in focal cerebral ischemia. Neurosurgery 1997; 40(2):364-370.
59. Watson JC, Doppenberg EM, Bullock MR, et al. Effects of the allosteric modification of hemoglobin on brain oxygen and infarct size in a feline model of stroke. Stroke 1997; 28(8):1624-1630.
60. Yatsugi S, Takahashi M, Kawasaki-Yatsugi S, et al. Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats. J Cereb Blood Flow Metab 1996; 16(5):959-966.
61. Akiho H, Iwai A, Tsukamoto S, et al. Neuroprotective effect of YM-39558 in focal cerebral ischemia in cats. Neuropharmacology 1998; 37(2):159-168.
62. Park CK, Nehls DG, Graham DI, et al. Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia. J Cereb Blood Flow Metab 1988; 8(5):757-762.
63. Gotti B, Duverger D, Bertin J, et al. Ifenprodil and SL 0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther 1988; 247:1211-1221.
64. Baskin DS, Widmayer MA, Browning JL, et al. Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats. Stroke 1994; 25(10):2047-2053.
65. Heiss WD, Graf R, Wienhard K, et al. Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 1994; 14:892-902.
66. Baron JC. Mapping the ischaemic penumbra with PET: Implications for acute stroke treatment. Cerebrovasc Dis 1999; 9:193-201.
67. Heiss WD, Graf R, Lottgen J, et al. Repeat positron emission tomographic studies in transient middle cerebral artery occlusion in cats: residual perfusion and efficacy of postischemic reperfusion. J Cereb Blood Flow Metab 1997; 17:388-400.
68. Fukuda S, del Zoppo GJ. Models of focal cerebral ischemia in the nonhuman primate. Ilar J 2003; 44:96-104.
69. DeGirolami U, Crowell RM, Marcoux FW. Selective necrosis and total necrosis in focal cerebral ischemia. Neuropathologic observations on experimental middle cerebral artery occlusion in the macaque monkey. J Neuropath Exp Neurol 1984; 43:57-71.
70. Meier-Ruge W, Bruder A, Theodore D. Histochemical and morphometric investigation of the pathogenesis of acute brain infarction in primates. Acta Histochemica 1992; 42:S59-S70.
71. Giffard C, Young AR, Mézenge F, et al. Histopathological effects of delayed reperfusion after middle cerebral artery occlusion in the anesthetized baboon. Brain Res Bull 2005; 30(4):335-340.
72. Young AR, Touzani O, Derlon JM, et al. Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion: a quantitative analysis of infarction volume. Stroke 1997; 28:632-737.
73. Jones TH, Morawetz RB, Crowell RM, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981; 54:773-782.
74. STAIR: Stroke Therapy Academic Industry Roundtable. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999; 30:2752-2758.
75. Takamatsu H, Tsukada H, Noda A, et al. FK506 attenuates early ischemic neuronal death in a monkey model of stroke. J Nucl Med 2001; 42(12):1833-1840.
76. Furuichi Y, Maeda M, Moriguchi A, et al. Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primates. J Cereb Blood Flow Metab 2003; 23(10):1183-1194.
77. Marshall JW, Cummings RM, Bowes LJ, et al. Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion. Stroke 2003; 34(9):2228-2233.
78. Lees KR, Zivin JA, Ashwood T, et al. NXY-059 for acute ischemic stroke. N Engl J Med 2006; 354(6):588-600.
79. Pappata S, Fiorelli M, Rommel T, et al. PET study of changes in local brain hemodynamics and oxygen metabolism after unilateral middle cerebral artery occlusion in baboons. J Cereb Blood Flow Metab 1993; 13:416-424.
80. Touzani O, Young AR, Derlon JM, et al. Sequential studies of severely hypometabolic tissue volumes after permanent middle cerebral artery occlusion. A positron emission tomographic investigation in anesthetized baboons. Stroke 1995; 26:2112-2119.
81. Touzani O, Young AR, Derlon JM, et al. Progressive impairment of brain oxidative metabolism reversed by reperfusion following middle cerebral artery occlusion in anaesthetized baboons. Brain Res 1997; 767:17-25.
82. Young AR, Sette G, Touzani O, et al. Relationships between high oxygen extraction fraction in the acute stage and final infarction in reversible middle cerebral artery occlusion. An investigation in anaesthetized baboons with positron emission tomography. J Cereb Blood Flow Metab 1996; 16:1176-1188.
83. Maeda M, Takamatsu H, Furuichi Y, et al. Characterization of a novel thrombotic middle cerebral artery occlusion model in monkeys that exhibits progressive hypoperfusion and robust cortical infarction. J Neurosci Methods 2005; 146:106-115.
84. Marchal G, Serrati C, Rioux P, et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome. Lancet 1993; 341:2-4.
85. Baron JC. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001; 11(suppl 1):2-8.
86. Baron JC. Mapping the ischaemic penumbra with PET: a new approach. Brain 2001; 124:2-4 (Editorial).
87. Marchal G, Beaudouin V, Rioux P, et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke 1996; 27:599-606.
88. Baron JC, Bousser MG, Comar D, et al. Non invasive tomographic study of cerebral blood flow and oxygen metabolism in vivo: potentials, limitations and clinical applications in cerebral ischemic disorders. Eur Neurol 1981; 20:273-284.
89. Wise RJS, Bernardi S, Frackowiak RSJ, et al. Serial observations on the pathophysiology of acute stroke. The transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain 1983; 106:197-222.
90. Furlan M, Marchal G, Viader F, et al. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996; 40:216-226.
91. Read SJ, Hirano T, Abbott DF, et al. Identifying hypoxic tissue after acute ischemic stroke using PET and 18f-fluoromisonidazole. Neurology 1998; 51:1617-1621.
92. Read SJ, Hirano T, Abbott DF, et al. The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol 2000; 48:228-235.
93. Markus R, Reutens DC, Kazui S, et al: Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. Brain 2004; 127:1427-1436.
94. Baird AE, Benfield A, Schlaug G, et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 1997; 41(5):581-589.
95. Beaulieu C, de Crespigny A, Tong DC, et al. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neurol 1999; 46:568-578.
96. Schwamm LH, Koroshetz WJ, Sorensen AG, et al. Time course of lesion development in patients with acute stroke: serial diffusion-and hemodynamic-weighted magnetic resonance imaging. Stroke 1998; 29:2268-2276.
97. Darby DG, Barber PA, Gerraty RP, et al. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 1999; 30:2043-2052.
98. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusionand diffusion-weighted MRI. Neurology 1998; 51:418-426.
99. Baird AE, Lovblad KO, Dashe JF, et al. Clinical correlations of diffusion and perfusion lesion volumes in acute ischemic stroke. Cerebrovasc Dis 2000; 10(6):441-448.
100. Heiss WD, Kracht LW, Thiel A, et al. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 2001; 124:20-29.
101. Lassen NA. Pathophysiology of brain ischemia as it relates to the therapy of acute ischemic stroke. Clin Neuropharmacol 1990; 13(suppl 3):S1-S8.
102. Kaufmann AM, Firlik AD, Fukui MB, et al. Ischemic core and penumbra in human stroke. Stroke 1999; 30:93-99.
103. Baron JC, Marchal G. Ischemic core and penumbra in human stroke. Stroke 1999; 30:1150-(letter)
104. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
105. Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. Stroke 1995; 26:2219-2221.
106. Furlan A, Higashida R, Weschsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282(21):2003-2011.
107. Ribo M, Molina CA, Rovira A, et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3-6-h window using multimodal transcranial Doppler/MRI selection protocol. Stroke 2005; 36:602-606.
108. Hacke W, Albers G, Al-Raw Y, et al. DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36(1):66-73.
109. Furlan AJ, Eyding D, Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006; 37(5):1227-1231.
110. Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke. Emerging pharmacological, mechanical, and imaging strategies. Stroke 2005; 36:2311-2320.
111. Marchal G, Rioux P, Serrati C, et al. Value of acute-stage positron emission tomography in predicting neurological outcome after ischemic stroke: further assessment. Stroke 1995; 26(3):524-525.
112. Kidwell CS, Saver JL, Mattiello J, et al. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology 2001; 57(11):2015-2021.
113. Thomalla GJ, Kucinski T, Schoder V, et al. Prediction of malignant middle cerebral artery infarction by early perfusion-and diffusion-weighted magnetic resonance imaging. Stroke 2003; 34(8):1892-1899.
114. Symon L, Branston NM, Strong AJ Extracellular potassium activity, evoked potential and rCBF during experimental cerebral ischaemia in the baboon. Acta Neurol Scand Suppl. 1977; 64:110-111.
115. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 1981; 12:723-725.
116. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36:557-565.
117. Touzani O, Roussel S, MacKenzie ET. The ischaemic penumbra. Curr Opin Neurol 2001; 14(1):83-88.
118. Clarke DD, Sokoloff L. Circulation and energy metabolism of the brain. In: Siegl GJ et al. eds. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th ed. Philadelphia: Lippincott-Raven Publishers, 1999:637-670.
119. Tower DB, Young OM. The activities of butyrylcholinesterase and carbonic anhydrase, the rate of anaerobic glycolysis, and the question of a constant density of glial cells in cerebral cortices of various mammalian species from mouse to whale. J Neurochem 1973; 20(2):269-278.
120. Kennedy C, Sakurada O, Shinohara M, et al. Local cerebral glucose utilization in the normal conscious macaque monkey. Ann Neurol 1978; 4(4):293-301.
121. Harris RJ, Symon L. Extracellular pH, potassium, and calcium activities in progressive ischaemia of rat cortex. J Cereb Blood Flow Metab 1984; 4(2):178-186.
122. Astrup J, Symon L, Branston NM, et al. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 1977; 8:51-57.
123. Bolander HG, Persson L, Hillered L, et al. Regional cerebral blood flow and histopathological changes after middle cerebral artery occlusion in rats. Stroke 1989; 20:930-937.
124. Tamura A, Graham DI, McCulloch J, et al. Focal cerebral ischaemia in the rat: Regional cerebral blood flow determined by [14C]iodoantipyrine autoradiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981; 1(1):61-69.
125. Zhao W, Belayev L, Ginsberg MD. Transient Middle Cerebral Artery Occlusion by Intraluminal Suture: II. Neurological Deficits, and Pixel-Based Correlation of Histopathology with Local Blood Flow and Glucose Utilization. J Cereb Blood Flow Metab 1997; 17, 1281-1290.
126. Tyson GW, Teasdale GM, Graham DI, et al. Focal cerebral ischemia in the rat: topography of hemodynamic and histopathologic changes. Ann Neurol 1984; 15:559-567.
127. Hakim AM, Hogan MJ, Carpenter S. Time course of cerebral blood flow and histological outcome after focal cerebral ischemia in rats. Stroke 1992; 23(8):1138-1143.
128. Jacewicz M, Tanabe J, Pulsinelli W.A. The CBF threshold and dynamics for focal cerebral infarction in spontaneously hypertensive rats. J Cereb Blood Flow Metab 1992; 12:359-370.
129. Duverger D, MacKenzie ET. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J Cereb Blood Flow Metab 1988; 8(4):449-461.
130. Hoehn-Berlage M, Norris DG, Kohno K, et al. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances. J Cereb Blood Flow Metab 1995; 15:1002-1011.
131. Kohno K, Hoehn-Berlage M, Mies G, et al. Relationship between diffusion-weighted MR images, cerebral blood flow, and energy state in experimental brain infarction. Magn Reson Imaging 1995; 13:73-80.
132. Mies G, Xie, Y, Seo, K, et al. Ischemic thresholods of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 1991; 11:753-761.
133. Heiss WD, Rosner G. Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol 1983; 14:294-301.
134. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982; 11(5):491-498.
135. Mies, G, Auer, L.M, Ebhardt, G, et al. Flow and neuronal density in tissue surrounding chronic infarction. Stroke 1983; 14:22-27.
136. Garcia JH, Liu KF, Ye ZR, Gutierre JA. Incomplete infarct and delayed neuronal death after transient middle cerebral artery oclusion in rats. Stroke 1997:28(11):2303-2309.
137. Torvik A, Svindland A. Is there a transitional zone between brain infarcts and the surrounding brain? A histological study. Acta Neurol Scand 1986; 74:365-370.
138. Baron JC. How healthy is the acutely reperfused ischemic penumbra? Cerebrovasc Dis 2005; 20(suppl 2):25-31.
139. Tamura A, Asano T, Sano K. Correlation between rCBF and histological changes following temporary middle cerebral artery occlusion. Stroke 1980; 11:487-493.
140. Marcoux FW, Morawetz RB, Crowell RM, et al. Differential regional vulnerability in transient focal cerebral ischemia. Stroke 1982; 13:339-346.
141. Miyabe M, Mori S, van Zijl PCM, et al. Correlation of the average water diffusion constant with cerebral blood flow and ischemic damage after transient middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 1996; 16:881-891.
142. Branston NM, Symon L, Crockard HA, et al. Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon. Exp Neurol 1974; 45(2):195-208.
143. Branston NM, Symon L, Crockard HA. Recovery of the cortical evoked response following temporary middle cerebral artery occlusion in baboons: relation to local blood flow and POStroke 1976; 7(2):151-157.
144. Morawetz RB, Crowell RH, DeGirolami U, et al. Regional cerebral blood flow thresholds during cerebral ischemia. Fed Proc 1979; 38(11):2493-24934.
145. Morawetz RB, De Girolami U, Ojemann RG, et al. Cerebral blood flow determined by hydrogen clearance during middle cerebral artery occlusion in unanesthetized monkeys. Stroke 1978; 9:143-149.
146. Yonas H, Gur D, Classen D et al. Stable xenon enhanced computed tomography in the study of clinical and pathologic correlates of focal ischemia in baboons. Stroke 1988 19(2):228-238.
147. Yonas H, Gur D, Classen D et al. Stable exnon-enhanced CT measurement of cerebral blood flow in reversible focal ischemia in baboons. J Neurosurg 1990:73(2):266-273.
148. Kuge Y, Yokota C, Tagaya M, et al. Serial changes in cerebral blood flow and flow-metabolism uncoupling in primates with acute thromboembolic. J Cereb Blood Flow Metab 2001; 21(3):202-210.
149. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab 2000; 20(9):1276-1293.
150. Baron JC, Rougemont D, Bousser M-G, et al. Local CBF, oxygen extraction fraction (OEF), and CMRO2: Prognostic value in recent supratentorial infarction in humans. J Cereb Blood Flow Metab 1983; 3(suppl 1):S1-S2.
151. Baron JC, Rougernont D, Soussaline F et al. Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients; a positron tomography study J Cereb Blood Flow Metab 1984;4(2):140-149.
152. Powers W, Grubb R, Darriet D, et al. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab 1985; 5:600-608
153. Hakim AM, Evans AC, Berger L, et al. The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J Cereb Blood Flow Metab 1989; 9(4):523-534.
154. Marchal G, Benali K, Iglesias S, et al. Voxel-based mapping of irreversible ischemic damage with PET in acute stroke. Brain 1999; 122:2387-2400.
155. Shimosegawa E, Hatazawa J, Ibaraki M, Toyoshima H, Suzuki A. Metabolic penumbra of acute brain infarction: A correlation with infarct growth. Ann Neurol 2005;57:495-500
156. Heiss WD, Huber M, Fink GR et al. Progressive derangement of perinfarct viable tissue in ischemic stroke J Cereb Blood Flow Metab 1992;12(2):193-203.
157. Heiss WD, Grond M, et al. Permanent Cortical Damage Detected by Flumazenil Positron Emission Tomography in Acute Stroke. Stroke. 1998; 29:454-461.
158. Lee JM, Vo KD, An H, et al. Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol 2003; 53(2):227-232.
159. Ueda T, Sakaki S, Yuh WT, et al.Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab 1999; 19(1):99-108.
160. Umemura A, Suzuka T, Yamada K. Quantitative measurement of cerebral blood flow by (99m)Tc-HMPAO SPECT in acute ischaemic stroke: usefulness in determining therapeutic options. J Neurol Neurosurg Psychiatry 2000; 69(4):472-478.
161. Wintermark M, Reichhart M, Cuisenaire O, et al. Comparison of admission perfusion computed tomography and qualitative diffusion-and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 2002a; 33:2025-31.
162. Wintermark M, Reichhart M, Thiran JP, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002b; 51:417-32.
163. Bristow MS, Simon JE, Brown RA, et al. perfusion and diffusion in acute ischemic stroke: human gray and white matter have different thresholds for infarction. J Cereb Blood Flow Metab 2005; 25(10):1280-1287.
164. Lin W, Lee JM, Lee YZ, et al. Temporal relationship between apparent diffusion coefficient and absolute measurements of cerebral blood flow in acute stroke patients. Stroke 2003; 34:64-70.
165. Fiehler J, von Bezold M, Kucinski T, et al. Cerebral blood flow predicts lesion growth in acute stroke patients. Stroke. 2002; Oct;33(10):2421-2425.
166. Wu O, Koroshetz WJ, Ostergaard L, et al. Predicting tissue outcome in acute human cerebral ischemia using combined diffusion-and perfusionweighted MR imaging. Stroke 2001; 32:933-942.
167. Shen Q, Ren H, Fisher M, Duong TQ. Statistical prediction of tissue fate in acute ischemic brain injury. J Cereb Blood Flow Metab 2005; 25:1336-1345
168. Ackerman RH, Lev MH, Mackay BC, et al. PET studies in acute stroke: Findings and relevance to therapy. J Cereb Blood Flow Metab 1989; 9(suppl 1):S359
169. Ezura M, Takahashi A, Yoshimoto T. Evaluation of regional cerebral blood flow using single photon emission tomography for the selection of patients for local fibrinolytic therapy of acute cerebral embolism. Neurosurg Rev 1996; 19(4):231-236.
170. Liu Y, Karonen JO, Vanninen RL, et al. Cerebral hemodynamics in human acute ischemic stroke: a study with diffusion-and perfusion-weighted magnetic resonance imaging and SPECT. J Cereb Blood Flow Metab 2000; 20(6):910-920.
171. Rohl L, Ostergaard L, Simonsen CZ, et al. Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke 2001 32(5):1140-1146.